N/A
Completed N=630
Identifying Patients With Dementia in Primary Care
Dementia · Memory Disorders
Source: ClinicalTrials.gov NCT00289471 ↗
Enrolled (actual)
630
Serious AEs
0.0%
Results posted
Aug 2014
Primary outcomePrimary: Performance Characteristics — 86; 79 Percentage of participants
Summary
Veterans who completed GEMS-Phase 1 will be asked to participate in GEMS-Phase 2 to determine the accuracy of methods used to assess mild memory problems. This will better help us evaluate the screening test completed in GEMS-Phase 1. The goals are:
1. Compare the assessment of memory made at the initial visit to assessments of memory made at the second evaluation.
2. Determine of veterans with mild memory problems have improvement or worsening of these memory problems over time. Our long-term goal remains to optimize the quality of care for veterans with cognitive impairment. We will also determine if patient characteristics can be used to target case-finding, describe the current process of care and evaluate the association between cognitive impairment and overall- and dementia-related health care utilization and costs.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Performance Characteristics |
86; 79 | — |
Eligibility Criteria
Inclusion Criteria
- Previous participant who completed GEMS-Phase 1
- Continues to be a VA clinic patient
- Identifies a key informant with phone
Exclusion Criteria
- Severe hearing or visual impairment
- Acute medical condition
Data sourced from ClinicalTrials.gov (NCT00289471). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.